Stanley-backed SEPRO Scientific acquires Bend Genetics
The Sacramento aquatic testing laboratory gives SEPRO a West Coast counterpart to its North Carolina facility.
- Target
- Bend Genetics
- Acquirer
- SEPRO Scientific
- Backed by
- Stanley Capital Partners
- Status
- Completed
- Announced
SEPRO Scientific acquired Bend Genetics, a laboratory that tests water for harmful algae and toxins. Bend also uses environmental DNA and other molecular methods to help water managers monitor aquatic conditions.
SEPRO said Bend would keep its Sacramento location, team and testing accreditations. Stanley Capital Partners lists SEPRO as a current investment. Stanley took a majority stake in 2024 alongside Goldman Sachs Alternatives, which participated as a minority investor.
Background
- Business
- Aquatic diagnostics laboratory specializing in algal bloom and toxin testing
- Deal type
- Add-on
- Headquarters
- Sacramento, California
Sources
- SEPRO ScientificNov 17, 2026
- Stanley Capital Partners
- Stanley Capital PartnersJul 29, 2024
- SEPRO ScientificJul 7, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.
Browse Business Services deals
Follow coverage. Copy a feed link into your feed reader.